R&D Innovating in clinical trial recruitment Clinical trial recruitment is in crisis, with 80% of trials failing to recruit the required number of patients on time.
News The Havas Lynx Group appoints a brace of creative directors The Havas Lynx Group has bolstered its creative team, appointing Paul Watson and Nick Craske as creative directors.
News Havas Lynx launches trial recruitment agency Havas Lynx Faze The Havas Lynx Group has launched Havas Lynx Faze, a specialist clinical trial recruitment agency that will be led by Mark Evans.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
